- Home
- DCBO vs OCUL Comparison
DCBO vs OCUL Comparison
Compare DCBO & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCBO
- OCUL
- Stock Information
- Founded
- DCBO 2016
- OCUL 2006
- Country
- DCBO Canada
- OCUL United States
- Employees
- DCBO N/A
- OCUL N/A
- Industry
- DCBO
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- DCBO
- OCUL Health Care
- Exchange
- DCBO Nasdaq
- OCUL Nasdaq
- Market Cap
- DCBO N/A
- OCUL 1.2B
- IPO Year
- DCBO 2020
- OCUL 2014
- Fundamental
- Price
- DCBO $29.29
- OCUL $7.58
- Analyst Decision
- DCBO Strong Buy
- OCUL Strong Buy
- Analyst Count
- DCBO 7
- OCUL 9
- Target Price
- DCBO $53.29
- OCUL $16.22
- AVG Volume (30 Days)
- DCBO 88.0K
- OCUL 1.8M
- Earning Date
- DCBO 05-08-2025
- OCUL 03-03-2025
- Dividend Yield
- DCBO N/A
- OCUL N/A
- EPS Growth
- DCBO 975.00
- OCUL N/A
- EPS
- DCBO 0.86
- OCUL N/A
- Revenue
- DCBO $216,931,000.00
- OCUL $63,723,000.00
- Revenue This Year
- DCBO $13.92
- OCUL $14.02
- Revenue Next Year
- DCBO $14.54
- OCUL $15.47
- P/E Ratio
- DCBO $34.06
- OCUL N/A
- Revenue Growth
- DCBO 19.96
- OCUL 9.03
- 52 Week Low
- DCBO $27.61
- OCUL $4.06
- 52 Week High
- DCBO $53.86
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- DCBO 32.62
- OCUL 50.08
- Support Level
- DCBO $29.14
- OCUL $7.36
- Resistance Level
- DCBO $32.29
- OCUL $8.04
- Average True Range (ATR)
- DCBO 1.01
- OCUL 0.48
- MACD
- DCBO 0.44
- OCUL 0.01
- Stochastic Oscillator
- DCBO 13.04
- OCUL 18.29
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.